Dr. Paul Lohmann GmbH & Co. KGaA
Key Highlights
- Dr. Paul Lohmann® has a strong focus on customer-centric innovation, developing special requirements and individual solutions.
- The company's global presence is supported by a well-developed network of representatives and sales departments.
- Dr. Paul Lohmann® emphasizes independent action and enjoyment of work, which fosters a culture of continuous improvement.
- The company's commitment to quality and innovation has maintained its leading position in the industry for over 130 years.
- Dr. Paul Lohmann® integrates research and development with production, ensuring high-quality mineral salts for various industries.
About Dr. Paul Lohmann GmbH & Co. KGaA
Dr. Paul Lohmann GmbH & Co. KGaA is an international manufacturer of high-quality mineral salts, serving the pharmaceutical, food, nutritional supplement, cosmetic, and technical industries for over 130 years. With production sites in Emmerthal and Lüneburg, a research and development lab in Bratislava, and sales departments in Singapore, New York, Eindhoven, and Evry, the company employs over 500 people worldwide. Their commitment to independent action and customer orientation drives innovation and business success.
The company's well-developed representative network enhances its global distribution structure, ensuring reliable service and quality. Dr. Paul Lohmann® focuses on developing special customer requirements, individual solutions, and new product ideas, which are key to their business strategy.
Through continuous improvement and a broad customer orientation, Dr. Paul Lohmann® maintains its leading position in the industry, meeting the highest quality standards and serving a diverse range of sectors.
Company Facts
| Ownership Private Company |
Why Contact Dr. Paul Lohmann GmbH & Co. KGaA?
B2B professionals should contact Dr. Paul Lohmann GmbH & Co. KGaA for high-quality mineral salts and innovative solutions tailored to the pharmaceutical, food, and cosmetic industries. Their commitment to quality and customer orientation makes them a reliable partner for industry-specific needs.
Who Should Contact Dr. Paul Lohmann GmbH & Co. KGaA for Business?
Sales teams targeting the pharmaceutical, food, and cosmetic industries, recruiters seeking roles in research and development, and partners offering mineral salt solutions should reach out to Dr. Paul Lohmann GmbH & Co. KGaA.
Categories
- mineral salts
- pharmaceutical industry
- food industry
- cosmetic industry
- nutritional supplements
- technical minerals
- research and development
- global distribution
- customer-centric innovation
- quality standards
More Pharmaceutical Manufacturing Companies
Frequently Asked Questions
- What does Dr. Paul Lohmann GmbH & Co. KGaA do?
- Dr. Paul Lohmann GmbH & Co. KGaA is a manufacturer and developer of high-value mineral salts for various industries, though specific activities are not detailed in the provided snippets.
- How many employees does Dr. Paul Lohmann GmbH & Co. KGaA have?
- Dr. Paul Lohmann GmbH & Co. KGaA has approximately 106 employees.
- What industry is Dr. Paul Lohmann GmbH & Co. KGaA in?
- Dr. Paul Lohmann GmbH & Co. KGaA operates in Pharmaceutical Manufacturing, Food and Beverage Production, Cosmetic and Personal Care.
- When was Dr. Paul Lohmann GmbH & Co. KGaA founded?
- Dr. Paul Lohmann GmbH & Co. KGaA was founded in 1886.
- Is Dr. Paul Lohmann GmbH & Co. KGaA still active?
- Yes, Dr. Paul Lohmann GmbH & Co. KGaA was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Dr. Paul Lohmann GmbH & Co. KGaA?
- Research Dr. Paul Lohmann GmbH & Co. KGaA's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Dr. Paul Lohmann GmbH & Co. KGaA?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Dr. Paul Lohmann GmbH & Co. KGaA